<- Go home

Added to YB: 2020-10-29

Pitch date: 2020-10-29

LQDA:US [bullish]

Liquidia Corporation

+638.5%

current return

Author Info

No bio for this author

Company Info

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

Market Cap

$2.4B

Pitch Price

$4.52

Price Target

N/A

Dividend

N/A

EV/EBITDA

-23.66

P/E

-19.31

EV/Sales

35.84

Sector

Pharmaceuticals

Category

N/A

Show full summary:
Liquidia Corporation LQDA:US

A summary for this pitch has not been created yet.

Read full article (0 min)